Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-19-006278)

Filing Details

Accession Number:: 0001209191-19-006278
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-01-31 19:07:02
Reporting Period:: 2019-01-29

Accepted Time:: 2019-01-31 19:07:02
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
353569	Quidel Corp	QDEL	In Vitro & In Vivo Diagnostic Substances (2835)	942573850

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1406652	C Douglas Bryant	12544 High Bluff Drive, Suite 200 San Diego CA 92130	President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-01-29	25,250	$15.28	319,563	No	4	M	Direct
Common Stock	Disposition	2019-01-29	25,250	$55.09	294,313	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option	Disposition	2019-01-29	25,250	$0.00	25,250	$15.28

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
20,920	2014-01-18	2020-01-18	No	4	M	Direct

Footnotes

The weighted average sale price for these transactions was $55.09 per share, with a range of $54.94 to $55.48. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.